Lista de obras -

A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice ⬇️

artículo científico publicado el 21 de febrero de 2011

Adaptation of pandemic H1N1 influenza viruses in mice

artículo científico publicado en 2010

Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.

artículo científico publicado en 2007

Amino Acids in Hemagglutinin Antigenic Site B Determine Antigenic and Receptor Binding Differences between A(H3N2)v and Ancestral Seasonal H3N2 Influenza Viruses

artículo científico publicado en 2016

Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals

artículo científico publicado en 2018

B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccination

artículo científico publicado en 2013

Both influenza hemagglutinin and polymerase acidic genes are important for delayed pandemic 2009 H1N1 virus clearance in the ferret model.

artículo científico publicado en 2012

Changes in H5N1 influenza virus hemagglutinin receptor binding domain affect systemic spread.

scholarly article

Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants

artículo científico publicado en 2006

Comparative study of influenza virus replication in MDCK cells and in primary cells derived from adenoids and airway epithelium

artículo científico publicado en 2012

Competitive fitness of oseltamivir-sensitive and -resistant highly pathogenic H5N1 influenza viruses in a ferret model

artículo científico publicado en 2010

Contribution of H7 haemagglutinin to amantadine resistance and infectivity of influenza virus

artículo científico publicado en 2007

Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza Vaccine

artículo científico publicado en 2016

Decreased Neuraminidase Activity Is Important for the Adaptation of H5N1 Influenza Virus to Human Airway Epithelium ⬇️

artículo científico publicado el 29 de febrero de 2012

Detection of amantadine-resistant variants among avian influenza viruses isolated in North America and Asia

artículo científico publicado en 2005

Does Pandemic A/H1N1 Virus Have the Potential To Become More Pathogenic? ⬇️

artículo científico publicado el 16 de noviembre de 2010

Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferrets

artículo científico publicado en 2010

Effects of hemagglutinin amino acid substitutions in H9 influenza A virus escape mutants

artículo científico publicado en 2016

Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus

artículo científico publicado en 2007

Extensive mammalian ancestry of pandemic (H1N1) 2009 virus.

artículo científico publicado en 2010

Generation and characterization of interferon-lambda 1-resistant H1N1 influenza A viruses.

artículo científico publicado en 2017

Human-like receptor specificity does not affect the neuraminidase-inhibitor susceptibility of H5N1 influenza viruses

artículo científico publicado en 2008

Identification and quantification of defective virus genomes in high throughput sequencing data using DVG-profiler, a novel post-sequence alignment processing algorithm.

artículo científico publicado en 2019

Impact of Influenza A Virus Infection on the Proteomes of Human Bronchoepithelial Cells from Different Donors

artículo científico publicado en 2017

In vitro anti-influenza A activity of interferon (IFN)-λ1 combined with IFN-β or oseltamivir carboxylate.

artículo científico publicado en 2014

In vitro modeling of the interaction between human epithelial cells and lymphocytes upon influenza infection

artículo científico publicado en 2016

Inefficient transmission of H5N1 influenza viruses in a ferret contact model

artículo científico publicado en 2007

Influenza A virus hemagglutinin mutations associated with use of neuraminidase inhibitors correlate with decreased inhibition by anti-influenza antibodies

scientific article published on 29 November 2019

Influenza A virus-induced early activation of ERK and PI3K mediates V-ATPase-dependent intracellular pH change required for fusion

artículo científico publicado en 2010

Influenza H1 Mosaic Hemagglutinin Vaccine Induces Broad Immunity and Protection in Mice

artículo científico publicado en 2019

Influenza virus NS1 protein mutations at position 171 impact innate interferon responses by respiratory epithelial cells

artículo científico publicado en 2017

Interactions of oseltamivir-sensitive and -resistant highly pathogenic H5N1 influenza viruses in a ferret model

artículo científico publicado el 1 de mayo de 2011

Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination

artículo científico publicado en 2014

Intramuscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in mice

artículo científico publicado en 2008

Labeling of influenza viruses with synthetic fluorescent and biotin-labeled lipids

artículo científico publicado en 2014

Live attenuated and inactivated influenza vaccines in children

artículo científico publicado en 2014

Molecular changes associated with adaptation of human influenza A virus in embryonated chicken eggs

artículo científico publicado en 2006

Monoclonal antibodies differentially affect the interaction between the hemagglutinin of H9 influenza virus escape mutants and sialic receptors.

artículo científico publicado en 2004

Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.

artículo científico publicado en 2007

Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer

artículo científico publicado en 2011

Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice

artículo científico publicado en 2008

Pleiotropic effects of amino acid substitutions in H5 hemagglutinin of influenza A escape mutants.

artículo científico publicado en 2015

Pleiotropic effects of hemagglutinin amino acid substitutions of H5 influenza escape mutants.

artículo científico publicado en 2013

Protection from the 2009 H1N1 pandemic influenza by an antibody from combinatorial survivor-based libraries

artículo científico publicado en 2010

Rapid one-step biotinylation of biological and non-biological surfaces.

artículo científico publicado en 2018

Structural differences among hemagglutinins of influenza A virus subtypes are reflected in their antigenic architecture: analysis of H9 escape mutants.

artículo científico publicado en 2004

Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants

artículo científico publicado en 2002

Susceptibility of highly pathogenic H5N1 influenza viruses to the neuraminidase inhibitor oseltamivir differs in vitro and in a mouse model.

artículo científico publicado en 2009

The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04.

artículo científico publicado en 2006

The use of plant lectins to regulate H1N1 influenza A virus receptor binding activity.

artículo científico publicado en 2018

Lista de obras de

A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice ⬇️

Adaptation of pandemic H1N1 influenza viruses in mice

Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.

Amino Acids in Hemagglutinin Antigenic Site B Determine Antigenic and Receptor Binding Differences between A(H3N2)v and Ancestral Seasonal H3N2 Influenza Viruses

Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals

B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccination

Both influenza hemagglutinin and polymerase acidic genes are important for delayed pandemic 2009 H1N1 virus clearance in the ferret model.

Changes in H5N1 influenza virus hemagglutinin receptor binding domain affect systemic spread.

Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants

Comparative study of influenza virus replication in MDCK cells and in primary cells derived from adenoids and airway epithelium

Competitive fitness of oseltamivir-sensitive and -resistant highly pathogenic H5N1 influenza viruses in a ferret model

Contribution of H7 haemagglutinin to amantadine resistance and infectivity of influenza virus

Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza Vaccine

Decreased Neuraminidase Activity Is Important for the Adaptation of H5N1 Influenza Virus to Human Airway Epithelium ⬇️

Detection of amantadine-resistant variants among avian influenza viruses isolated in North America and Asia

Does Pandemic A/H1N1 Virus Have the Potential To Become More Pathogenic? ⬇️

Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferrets

Effects of hemagglutinin amino acid substitutions in H9 influenza A virus escape mutants

Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus

Extensive mammalian ancestry of pandemic (H1N1) 2009 virus.

Generation and characterization of interferon-lambda 1-resistant H1N1 influenza A viruses.

Human-like receptor specificity does not affect the neuraminidase-inhibitor susceptibility of H5N1 influenza viruses

Identification and quantification of defective virus genomes in high throughput sequencing data using DVG-profiler, a novel post-sequence alignment processing algorithm.

Impact of Influenza A Virus Infection on the Proteomes of Human Bronchoepithelial Cells from Different Donors

In vitro anti-influenza A activity of interferon (IFN)-λ1 combined with IFN-β or oseltamivir carboxylate.

In vitro modeling of the interaction between human epithelial cells and lymphocytes upon influenza infection

Inefficient transmission of H5N1 influenza viruses in a ferret contact model

Influenza A virus hemagglutinin mutations associated with use of neuraminidase inhibitors correlate with decreased inhibition by anti-influenza antibodies

Influenza A virus-induced early activation of ERK and PI3K mediates V-ATPase-dependent intracellular pH change required for fusion

Influenza H1 Mosaic Hemagglutinin Vaccine Induces Broad Immunity and Protection in Mice

Influenza virus NS1 protein mutations at position 171 impact innate interferon responses by respiratory epithelial cells

Interactions of oseltamivir-sensitive and -resistant highly pathogenic H5N1 influenza viruses in a ferret model

Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination

Intramuscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in mice

Labeling of influenza viruses with synthetic fluorescent and biotin-labeled lipids

Live attenuated and inactivated influenza vaccines in children

Molecular changes associated with adaptation of human influenza A virus in embryonated chicken eggs

Monoclonal antibodies differentially affect the interaction between the hemagglutinin of H9 influenza virus escape mutants and sialic receptors.

Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.

Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer

Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice

Pleiotropic effects of amino acid substitutions in H5 hemagglutinin of influenza A escape mutants.

Pleiotropic effects of hemagglutinin amino acid substitutions of H5 influenza escape mutants.

Protection from the 2009 H1N1 pandemic influenza by an antibody from combinatorial survivor-based libraries

Rapid one-step biotinylation of biological and non-biological surfaces.

Structural differences among hemagglutinins of influenza A virus subtypes are reflected in their antigenic architecture: analysis of H9 escape mutants.

Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants

Susceptibility of highly pathogenic H5N1 influenza viruses to the neuraminidase inhibitor oseltamivir differs in vitro and in a mouse model.

The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04.

The use of plant lectins to regulate H1N1 influenza A virus receptor binding activity.